Researchers at The Ohio State University Comprehensive Cancer Center have made a significant breakthrough in the fight against glioblastoma, one of the deadliest forms of cancer. The discovery of SET as a potential target for treatment could pave the way for new therapies that increase the effectiveness of radiation and chemotherapy.
Key Insights
Glioblastoma is a highly aggressive brain cancer with limited treatment options, and current tumors often develop resistance to radiation and chemotherapy. The identification of SET as a potential target highlights the potential for developing new therapies that could improve treatment outcomes for patients with this devastating disease.
